Concepedia

Péter Sandy

PS

Statistics

Publications

30

Citations

9K

H-Index

24

Active since

1999

Affiliations

Constellation Pharmaceuticals (United States)(Current)

Massachusetts Institute of Technology

Consorzio Interuniversitario per le Biotecnologie

Howard Hughes Medical Institute

Harvard University

Péter Sandy is an author at Constellation Pharmaceuticals (United States) specializing in molecular oncology, medicine, and pharmacology.

Publications per year

1999–2022

30

Publications

30

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

David A. Barbie, Pablo Tamayo, Jesse S. Boehm et al. · Nature · 2009 · 4.2K citations · Full text

, , +13

Targeting MYC dependence in cancer by inhibiting BET bromodomains

Jennifer A. Mertz, Andrew R. Conery, Barbara M. Bryant et al. · Proceedings of the National Academy of Sciences · 2011 · 1.1K citations · Full text

, , +17

Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells

Claudia Scholl, Stefan Fröhling, Ian F. Dunn et al. · Cell · 2009 · 543 citations · Full text

, , +16

AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer

Péter Sandy, Sebastian Hoersch, Piyush B. Gupta et al. · DSpace@MIT (Massachusetts Institute of Technology) · 2009 · 541 citations · Full text

, , +16

Activation of p53 by conjugation to the ubiquitin‐like protein SUMO‐1

Monica Gostissa, Arnd Hengstermann, Valentina Fogal et al. · The EMBO Journal · 1999 · 509 citations

, , +7

1–5 of 30